methyl-3-methoxy-4-(3-(4-(2-methyl-1,3-dioxolan-2-yl)-3-oxobutyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl)but-2-enoate

ID: ALA5172463

PubChem CID: 168270251

Max Phase: Preclinical

Molecular Formula: C24H26O8

Molecular Weight: 442.46

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)/C=C(/CC1=C(CCC(=O)CC2(C)OCCO2)C(=O)c2ccccc2C1=O)OC

Standard InChI:  InChI=1S/C24H26O8/c1-24(31-10-11-32-24)14-15(25)8-9-19-20(12-16(29-2)13-21(26)30-3)23(28)18-7-5-4-6-17(18)22(19)27/h4-7,13H,8-12,14H2,1-3H3/b16-13-

Standard InChI Key:  BCOULIQWVANRPO-SSZFMOIBSA-N

Molfile:  

 
     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   -3.5718   -0.6040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8572   -0.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1454   -0.6036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1454   -1.4288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8554   -1.8405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5718   -1.4325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4276   -1.8429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7159   -1.4262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7159   -0.6052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4327   -0.1927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4327    0.6324    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4276   -2.6680    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0031   -0.1926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0031    0.6324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7114    1.0451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7177    1.0451    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7177    1.8703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7114    1.8703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4261    2.2829    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0031    2.2829    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4261    3.1081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0011   -1.8388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7131   -1.4262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4279   -1.8388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1426   -1.4262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4279   -2.6640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8571   -1.8388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5718   -1.4262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5245   -2.3236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2696   -3.1081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4448   -3.1081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2315   -2.3123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  3 10  1  0
 10 11  2  0
  7 12  2  0
  9 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
  8 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 27 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5172463

    ---

Associated Targets(Human)

HCC1954 (381 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-549 (31254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAL-51 (262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 442.46Molecular Weight (Monoisotopic): 442.1628AlogP: 2.96#Rotatable Bonds: 9
Polar Surface Area: 105.20Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.28CX LogD: 2.28
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.33Np Likeness Score: 0.76

References

1. Furqan M, Fayyaz A, Firdous F, Raza H, Bilal A, Saleem RSZ, Shahzad-Ul-Hussan S, Wang D, Youssef FS, Al Musayeib NM, Ashour ML, Hussain H, Faisal A..  (2022)  Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.,  85  (6.0): [PMID:35687347] [10.1021/acs.jnatprod.1c01222]

Source